MA46898A - Compositions pour la conservation d'organes - Google Patents
Compositions pour la conservation d'organesInfo
- Publication number
- MA46898A MA46898A MA046898A MA46898A MA46898A MA 46898 A MA46898 A MA 46898A MA 046898 A MA046898 A MA 046898A MA 46898 A MA46898 A MA 46898A MA 46898 A MA46898 A MA 46898A
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- organ conservation
- conservation
- organ
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/03—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP1600639 | 2016-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46898A true MA46898A (fr) | 2019-10-02 |
Family
ID=89720188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046898A MA46898A (fr) | 2016-11-24 | 2017-11-24 | Compositions pour la conservation d'organes |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12239125B2 (fr) |
| EP (1) | EP3544420B8 (fr) |
| CN (1) | CN110337244B (fr) |
| CA (1) | CA3044746A1 (fr) |
| DK (1) | DK3544420T3 (fr) |
| ES (1) | ES2926179T3 (fr) |
| HU (1) | HUE060027T2 (fr) |
| IL (1) | IL266833B (fr) |
| MA (1) | MA46898A (fr) |
| PL (1) | PL3544420T3 (fr) |
| WO (1) | WO2018096376A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10575515B2 (en) | 2010-05-04 | 2020-03-03 | The General Hospital Corporation | Methods and compositions for preserving tissues and organs |
| WO2015138832A1 (fr) | 2014-03-13 | 2015-09-17 | The General Hospital Corporation | Dispositifs et des méthodes pour améliorer et évaluer la viabilité de foies humains |
| EP3638019A4 (fr) | 2017-06-14 | 2020-08-26 | The General Hospital Corporation | Cryoconservation à très basse température |
| WO2019232268A1 (fr) | 2018-05-30 | 2019-12-05 | Mustafa Korkut Uygun | Cryoconservation de tissus et d'organes |
| WO2022241417A1 (fr) * | 2021-05-10 | 2022-11-17 | The General Hospital Corporation | Méthodes et compositions pour prolonger la conservation d'un organe et d'un tissu |
| WO2026146290A1 (fr) | 2024-12-30 | 2026-07-09 | Hun-Ren Támogatott Kutatócsoportok Irodája | Utilisation de dérivés de fluvoxamine pour la conservation d'organes |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3692835A (en) | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
| NL7503312A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| NL7503310A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| NL7503309A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| US4083978A (en) | 1976-01-27 | 1978-04-11 | Egyt Gyogyszervegyeszeti Gyar | Oxime ethers |
| US5086054A (en) | 1990-07-31 | 1992-02-04 | Sri International | Novel arylcycloalkanepolyalkylamines |
| US6297212B1 (en) | 1994-05-31 | 2001-10-02 | Gregory M. Fahy | Growth hormone therapy and related methods and pharmaceutical compositions |
| IN184685B (fr) * | 1996-02-14 | 2000-09-23 | Nat Inst Immunology | |
| IN186677B (fr) | 1999-11-12 | 2001-10-20 | Sun Pharmaceutical Ind Ltd | |
| US8765364B2 (en) * | 2007-05-18 | 2014-07-01 | Lifeline Scientific, Inc. | Ex vivo methods for validating substance testing with human organs and/or tissues |
| KR101098583B1 (ko) * | 2008-01-04 | 2011-12-26 | 주식회사 엘지생명과학 | 세포, 조직 및 장기 보존 효과를 갖는 인돌 및 인다졸 유도체 |
| SE533552C2 (sv) | 2008-12-30 | 2010-10-26 | Igeloesa Transplantation Science Ab | Förfarande och lösning för behandling av en potentiell organdonator |
| EP2453893A4 (fr) | 2009-07-09 | 2012-06-20 | Ozteo Pty Ltd | Traitement de lésion de cellules, tissus et organes non neuronaux et non myocardiques et de la douleur associée à des inhibiteurs sodiques persistants |
| EP2353598A1 (fr) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour utilisation dans la prévention et/ou le traitement de la douleur post-opératoire |
| US20130018059A1 (en) * | 2010-03-31 | 2013-01-17 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (dmso) formulations for treating autism |
| SE534862C2 (sv) * | 2010-05-14 | 2012-01-24 | Vivoline Medical Ab | Användning av en medicinsk vätska för behandling av ett uttaget organ |
| US9333205B2 (en) * | 2010-07-30 | 2016-05-10 | Nerviano Medical Sciences S.R.L. | Isoxazolo-quinazolines as modulators of protein kinase activity |
| US20140255905A1 (en) | 2011-10-03 | 2014-09-11 | Vivoline Medical Ab | Medical fluid comprising globulin and its use for preservation of harvested organs |
| GB201120259D0 (en) * | 2011-11-24 | 2012-01-04 | Univ Gent | Allogeneic immune response control |
| WO2015118365A1 (fr) | 2014-02-07 | 2015-08-13 | Mta Támogatott Kutatócsoportok Irodája | Nouvelle utilisation de composés agonistes du récepteur sigma -1 |
| US10842794B2 (en) | 2014-02-07 | 2020-11-24 | Támogatott Kutatócsoportok Irodája | Use of Sigma-1 receptor agonist compounds |
| CN104292126B (zh) * | 2014-08-14 | 2016-08-24 | 广东东阳光药业有限公司 | 萘衍生物及其在药物上的应用 |
| US20170295776A1 (en) * | 2016-04-18 | 2017-10-19 | University Of Cincinnati | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells |
-
2017
- 2017-11-24 MA MA046898A patent/MA46898A/fr unknown
- 2017-11-24 WO PCT/HU2017/050051 patent/WO2018096376A1/fr not_active Ceased
- 2017-11-24 US US16/463,944 patent/US12239125B2/en active Active
- 2017-11-24 PL PL17829007.8T patent/PL3544420T3/pl unknown
- 2017-11-24 ES ES17829007T patent/ES2926179T3/es active Active
- 2017-11-24 HU HUE17829007A patent/HUE060027T2/hu unknown
- 2017-11-24 CN CN201780084580.9A patent/CN110337244B/zh active Active
- 2017-11-24 DK DK17829007.8T patent/DK3544420T3/da active
- 2017-11-24 EP EP17829007.8A patent/EP3544420B8/fr active Active
- 2017-11-24 CA CA3044746A patent/CA3044746A1/fr active Pending
-
2019
- 2019-05-23 IL IL266833A patent/IL266833B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3544420B8 (fr) | 2022-11-23 |
| IL266833B (en) | 2022-01-01 |
| EP3544420A1 (fr) | 2019-10-02 |
| US12239125B2 (en) | 2025-03-04 |
| US20190335745A1 (en) | 2019-11-07 |
| WO2018096376A1 (fr) | 2018-05-31 |
| IL266833A (en) | 2019-08-29 |
| EP3544420B1 (fr) | 2022-06-22 |
| PL3544420T3 (pl) | 2022-11-21 |
| DK3544420T3 (da) | 2022-09-05 |
| CN110337244A (zh) | 2019-10-15 |
| CN110337244B (zh) | 2023-07-21 |
| CA3044746A1 (fr) | 2018-05-31 |
| ES2926179T3 (es) | 2022-10-24 |
| HUE060027T2 (hu) | 2023-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3784285C0 (fr) | Agents cryoprotecteurs pour formulations particulaires | |
| EP3526328A4 (fr) | Polythérapie pour l'inhibition de c3 | |
| EP3446194A4 (fr) | Raccourcis d'application pour carplay | |
| EP3324840A4 (fr) | Tensiomètre pour l'estimation de débit | |
| MA71266A (fr) | Procédés d'intervention précoce pour prévenir ou améliorer la toxicité | |
| EP3630078A4 (fr) | Agents pour chimio-embolisation | |
| EP3656821A4 (fr) | Composition d'asphalte | |
| MA49006A (fr) | Inhibiteurs d'ip6k | |
| EP3265098A4 (fr) | Compositions permettant de moduler l'expression de mecp2 | |
| EP3365403A4 (fr) | Combinaison d'inhibiteurs de cobalt pour un bombage amélioré | |
| EP3463259A4 (fr) | Compositions d'écran solaire | |
| EP3277757A4 (fr) | Compositions pour l'inhibition de corrosion | |
| EP3627918C0 (fr) | Radiorecherche d'extension de couverture pour ec-gsm | |
| EP3612173A4 (fr) | Formulations pour la pulvérisation d'épinéphrine | |
| FR3022462B1 (fr) | Composition orale d'anticorps anti-tnfalpha | |
| MA39500A (fr) | Compositions à base d'extraits de plantes pour l'inhibition de la 5-alpha-réductase | |
| EP3403655A4 (fr) | Composition pour augmenter l'expression de pgc-1 | |
| EP3560902A4 (fr) | Composition pour marbre artificiel | |
| EP3431808A4 (fr) | Butée d'arrêt | |
| IL269695A (en) | Compounds useful as inhibitors of alcat 1 | |
| EP3302061A4 (fr) | Compositions d'urée à libération prolongée | |
| EP3408731A4 (fr) | Modes d'interaction pour interactions objet-dispositif | |
| FR3020758B1 (fr) | Composition pour ameliorer l'hygiene buco-dentaire | |
| EP3444345A4 (fr) | Dérivé d'arnmicro-143 | |
| EP3426210A4 (fr) | Produit d'incontinence |